Niemann-Pick Disease
What is Niemann-Pick Disease?
Niemann-Pick disease is a rare inherited condition that affects how your body breaks down fats. It happens when harmful amounts of a fatty substance called sphingomyelin build up in your organs, especially your liver, spleen, brain, and bone marrow. This buildup damages cells and prevents organs from working properly.
The disease is caused by mutations in genes that make enzymes needed to process fats. There are several types of Niemann-Pick disease, labeled A, B, and C. Type A is the most severe and usually affects infants. Type B is milder and often diagnosed in childhood or adulthood. Type C has a different genetic cause and affects the brain more than other organs.
This is a lysosomal storage disorder, which means the tiny recycling centers inside your cells cannot properly break down certain materials. Because the disease is genetic, it runs in families. Early detection through blood testing helps doctors monitor liver health and track how the disease progresses over time.
Symptoms
- Enlarged liver and spleen that can be felt during physical exams
- Yellowing of the skin or eyes from liver problems
- Frequent respiratory infections and breathing difficulties
- Difficulty with motor skills and muscle weakness
- Developmental delays in children or cognitive decline
- Vision problems including trouble moving eyes up and down
- Difficulty swallowing or slurred speech
- Unexplained fatigue and low energy levels
- Easy bruising or bleeding from low platelet counts
- Tremors or difficulty with balance and walking
Some people with milder forms of Niemann-Pick disease have few symptoms in early stages. Type B cases may go undetected until adulthood when liver enzyme abnormalities appear on routine blood work.
Concerned about Niemann-Pick Disease? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Niemann-Pick disease is caused by inherited genetic mutations that affect fat metabolism. Types A and B result from mutations in the SMPD1 gene, which makes an enzyme called acid sphingomyelinase. Type C comes from mutations in either the NPC1 or NPC2 gene. You must inherit a mutated gene from both parents to develop the disease. If you inherit only one mutated gene, you become a carrier without symptoms.
The disease is more common in certain populations due to founder effects. Ashkenazi Jewish families have higher rates of Type A. Type B affects people of all backgrounds but is more common in those of Turkish, North African, or Saudi Arabian descent. There are no lifestyle or environmental risk factors, only genetic inheritance patterns that determine who develops the condition.
How it's diagnosed
Doctors diagnose Niemann-Pick disease through a combination of clinical findings, blood tests, genetic testing, and sometimes tissue biopsies. Blood work often shows elevated liver enzymes like alanine aminotransferase or ALT, which indicates liver damage from fat buildup. Rite Aid testing measures ALT levels to help monitor liver health and track disease progression in people with known Niemann-Pick disease.
Specialized enzyme tests measure acid sphingomyelinase activity in white blood cells or skin samples. Genetic testing confirms the diagnosis by identifying specific mutations. Imaging studies like ultrasound, CT scans, or MRI show enlarged organs and assess brain involvement. A bone marrow biopsy may reveal foam cells, which are cells filled with stored fat. Regular ALT monitoring helps doctors evaluate how well treatments are working and whether liver damage is worsening over time.
Treatment options
- Enzyme replacement therapy with olipudase alfa for eligible Type B patients to reduce organ damage
- Miglustat medication for Type C to slow neurological decline in some cases
- Physical therapy to maintain muscle strength and mobility
- Occupational therapy to help with daily living skills
- Speech therapy for swallowing and communication difficulties
- Nutritional support including feeding tubes if swallowing becomes unsafe
- Regular monitoring of liver function through blood tests like ALT
- Respiratory support and treatments for lung complications
- Bone marrow transplant in select cases, though outcomes vary
- Supportive care for symptoms like seizures or sleep problems
Concerned about Niemann-Pick Disease? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Niemann-Pick disease is a rare genetic disorder where fat builds up in organs like the liver, spleen, and brain. This happens because your body lacks specific enzymes needed to break down sphingomyelin, a type of fat. Over time, this buildup damages organs and can affect breathing, movement, cognition, and liver function.
Early signs depend on the type. Infants with Type A may show poor feeding, developmental delays, and an enlarged belly from liver and spleen swelling. Type B often starts with repeated respiratory infections or discovery of organ enlargement during routine exams. Type C may begin with clumsiness, trouble in school, or unusual eye movements.
Blood tests cannot diagnose Niemann-Pick disease directly, but they reveal important clues. Elevated liver enzymes like ALT indicate liver damage from fat accumulation. Specialized enzyme activity tests on blood cells can confirm Types A and B. Genetic blood tests identify the specific mutations that cause all types of the disease.
ALT or alanine aminotransferase is a liver enzyme that rises when liver cells are damaged. In Niemann-Pick disease, fat buildup in liver cells causes ongoing damage and ALT elevation. Regular ALT monitoring helps doctors track liver health, assess disease progression, and evaluate how well treatments like enzyme replacement therapy are working.
Yes, Niemann-Pick disease is inherited in an autosomal recessive pattern. This means both parents must carry a mutated gene and pass it to their child. If both parents are carriers, each child has a 25 percent chance of having the disease and a 50 percent chance of being a carrier themselves.
There is no cure for Niemann-Pick disease currently. However, enzyme replacement therapy with olipudase alfa can reduce organ damage in Type B patients. Miglustat may slow brain decline in some Type C cases. Most treatment focuses on managing symptoms, supporting quality of life, and monitoring organ function with regular blood tests.
Testing frequency depends on your disease type, severity, and treatment plan. Many doctors recommend liver enzyme checks like ALT every 3 to 6 months to monitor liver health. If you are on enzyme replacement therapy, your doctor may order more frequent testing to track treatment response and adjust dosing.
Because this is a genetic enzyme deficiency, lifestyle changes cannot stop the disease. However, eating a balanced diet supports overall health and prevents additional liver stress. Regular physical therapy maintains mobility and muscle strength. Avoiding alcohol protects the liver from extra damage, and staying current on vaccinations prevents infections that can worsen symptoms.
Adults do not suddenly develop Niemann-Pick disease, but milder forms like Type B may not be diagnosed until adulthood. Some people have subtle symptoms for years before liver abnormalities show up on routine blood work. Type C can also present in teens or adults with gradual neurological symptoms that are sometimes mistaken for other conditions.
Life expectancy varies greatly by type. Type A is usually fatal in early childhood, often by age 3. Type B patients often survive into adulthood with proper care and newer treatments. Type C has a wide range, from childhood death to survival into the 40s or beyond depending on symptom onset and progression rate.